This expert consensus provides localized guidance for the diagnosis, screening, and management of familial hypercholesterolaemia in Hong Kong to address underdiagnosis and undertreatment.
Answers are grounded in this paper and cite their sources.
Provides localized FH guidance for Hong Kong; extends global consensus to reduce underdiagnosis and undertreatment.
In 2016, meetings of groups of physicians and paediatricians with a special interest in lipid disorders and familial hypercholesterolaemia were held to discuss several domains of management of familial hypercholesterolaemia in adults and children in Hong Kong. After reviewing the evidence and guidelines for the diagnosis, screening, and management of familial hypercholesterolaemia, consensus was reached on the following aspects: clinical features, diagnostic criteria, screening in adults, screening in children, management in relation to target plasma low-density lipoprotein cholesterol levels, detection of atherosclerosis, lifestyle and behaviour modification, and pharmacotherapy.
No takes yet. Share an insight, caveat, or question.
Tomlinson et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: